Patient number n 259
Mean age Mean±SD 63.89±6.08
Pre-operative Total PSA (ng/dl) n (%)
0-10 188 (72.6%)
11-20 56 (21.6%)
>20 15 (5.8%)
Clinical stage n (%)
T1c- T2a 219 (84.6%)
T2b 27 (10.4%)
T2c 13 (5.0%)
Total core number Median (min-max) 12 (6-30)
Positive core percentage Mean 33,77%
Pre-operative biopsy score n (%)
GS 3+3 186 (71.8%)
GS 3+4 45 (17.3%)
GS 4+3 16 (6.2%)
GS 4+4 8 (3.1%)
GS 3+5 3 (1.2%)
GS 4+5 1 (0.4%)
Biochemical recurrence n(%)
Yes 52 (20.1%)
No 207 (79.9%)
Follow-up time (month) Median (min-max) 60.0 (6.0-148.0)
BCR time (month) Median (min-max) 12.0 (3.0-48.0)